Mueller Brian 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Mueller Brian
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-03-14$69.44/sh−18,497$1,284,432→ 83,141 total - Award
Common Stock
2025-03-17+16,640→ 99,781 total - Award
Stock Option (Right to Buy Common Stock)
2025-03-17+38,590→ 38,590 totalExercise: $71.55From: 2026-03-17Exp: 2035-03-16→ Common Stock (38,590 underlying)
Footnotes (2)
- [F1]Restricted stock units granted March 17, 2025. Price not applicable.
- [F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.